RxDoctor Payments Data

Jennifer Farmer

Nurse Practitioner · Wagoner, OKNPI 1992965255

Payments from drug & device makers

$543in general payments, 2019–2025

Across 31 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$88
  • AbbVie$75
  • Novo Nordisk$58
  • Biohaven Pharmaceuticals, Inc.$51
  • Halozyme Inc$48
  • Pharmacosmos Therapeutics Inc.$44
  • plus $179 from 8 others

What the payments were for

  • Food & beverage$543100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$543 in reported general payments places this provider in the 75th percentile of 824 nurse practitioner providers in Oklahoma.

See all nurse practitioner providers in Oklahoma

Medicare billing

Part B allowed, 2024
$33,143
Medicare patients
88
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide33$36,640
OzempicSemaglutide19$27,036
TrulicityDulaglutide26$27,027
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$20,936
EliquisApixaban20$20,253
FarxigaDapagliflozin Propanediol15$12,961
MyrbetriqMirabegron16$12,537
JardianceEmpagliflozin19$10,340
Rosuvastatin Calcium125$2,931
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,562
Atorvastatin Calcium106$1,443
Levetiracetam21$1,336
Pantoprazole Sodium102$1,326
Levothyroxine Sodium170$1,116
Gabapentin101$1,111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$88$63,66859 claims
AstraZenecaBreztri Aerosphere, Farxiga$34$33,89738 claims
Novo NordiskOzempic$58$27,03619 claims
PfizerEliquis$42$20,25320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 824 nurse practitioner providers in Oklahoma.

Other nurse practitioner in Wagoner

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →